# FDA Inspection 1321164 - Annovex Pharma, Inc. - June 03, 2026

Source: https://www.keypedia.com/records/fda_inspections/annovex-pharma-inc/6c5d97b2-604d-4817-85e1-9b4bc3a0471f
Source feed: FDA_Inspections

> FDA Inspection 1321164 for Annovex Pharma, Inc. on June 03, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1321164
- Company Name: Annovex Pharma, Inc.
- Inspection Date: 2026-06-03
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Baltimore District Office

## Related Documents

- [FDA Inspection 1248991 - 2024-09-06](https://www.keypedia.com/records/fda_inspections/annovex-pharma-inc/36ae300a-c916-4ad4-b937-d971e54facb0)

Company: https://www.keypedia.com/companies/annovex-pharma-inc/24fc76c5-e88a-4b2d-9d3b-9e6edf3779b0

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa